GLIOMA GLIOBLASTOMA MULTIFORME
Clinical trials for GLIOMA GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new GLIOMA GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for GLIOMA GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug targets specific genetic weakness in tumors
Disease control Recruiting nowThis study is testing a new oral drug called TNG456, both alone and combined with another cancer drug (abemaciclib), in people with advanced solid tumors that have a specific genetic change called MTAP loss. The main goals are to find safe doses and see if the treatment can shrin…
Matched conditions: GLIOMA GLIOBLASTOMA MULTIFORME
Phase: PHASE1, PHASE2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Precision mapping could boost brain tumor treatment effectiveness
Disease control Recruiting nowThis study is testing whether using advanced MRI techniques to create personalized maps for electrical therapy devices works better than standard mapping for glioblastoma brain tumors. Participants who are starting the Optune electrical therapy will receive either standard mappin…
Matched conditions: GLIOMA GLIOBLASTOMA MULTIFORME
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC